APA (7th ed.) Citation

WT, L., CH, W., H, L., YC, O., HC, F., CC, T., . . . YY, C. (2026). Precision chemotherapy duration in advanced ovarian cancer: Neoadjuvant cycle optimization and differential treatment adaptation by cytoreduction outcome. American journal of cancer research, 16(3), 853. https://doi.org/10.62347/KESA6873

Chicago Style (17th ed.) Citation

WT, Lin, Wu CH, Lin H, Ou YC, Fu HC, Tsai CC, Wang YW, Huang SW, and Chen YY. "Precision Chemotherapy Duration in Advanced Ovarian Cancer: Neoadjuvant Cycle Optimization and Differential Treatment Adaptation by Cytoreduction Outcome." American Journal of Cancer Research 16, no. 3 (2026): 853. https://doi.org/10.62347/KESA6873.

MLA (9th ed.) Citation

WT, Lin, et al. "Precision Chemotherapy Duration in Advanced Ovarian Cancer: Neoadjuvant Cycle Optimization and Differential Treatment Adaptation by Cytoreduction Outcome." American Journal of Cancer Research, vol. 16, no. 3, 2026, p. 853, https://doi.org/10.62347/KESA6873.